The missing link between genotype, phenotype and clinics;Karika koja nedostaje izmedu genotipa, fenotipa i kliničkih nalaza

Biochemia Medica

Volumn 19, Issue 2, 2009, Pages 137-145

  Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Clinics; Genetic testing; Genotype; Phenotype

Indexed keywords

COUMARIN DERIVATIVE; LIPOPROTEIN; WARFARIN;

ENVIRONMENTAL FACTOR; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC PROCEDURES; GENOTYPE; HEMOPHILIA A; HEREDITY; HUMAN; MONOGENIC DISORDER; MULTIFACTORIAL INHERITANCE; OUTPATIENT DEPARTMENT; PATIENT CARE; PHENOTYPE; PHYLOGENY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW;

EID: 67649171019     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2009.013     Document Type: Review

References (33)

1. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001 ;409:860-921.
2. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
3. Oldenburg J, Ananyeva NM, Saenko EL. Molecular basis of haemophilia A. Haemophilia 2004; 10(Suppl 4): 133-9.
4. van den Berg HM, De Groot PH, Fischer K. Phenotypic heterogeneity in severe hemophilia. J Thromb Haemost2007;5(Suppl 1):151-6.
5. Jayandharan GR, Srivastava A. The phenotypic heterogeneity of severe hemophilia. Semin Thromb Hemost 2008;34:128-41.
6. Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood 2008;112:250-5.
7. Margaglione M, Castaman G, Morfini M, Rocino A, Santagostino E, et al. AICE-Genetics Study Group. The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematolo-gica 2008;93:722-8.
8. Sanna V, Zarrilli F, Nardiello P, D'Argenio V, Rocino A, Coppola A, et al. Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from southern Italy. Haemophilia 2008;14:796-803.
9. Salvagno GL, Astermark J, Lippi G, Ekman M, Franchini M, Guidi GC, Berntorp E. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia? Haemophilia 2009;15:290-6.
10. Schulman S, EeldeA, Holmström M, Ståhlberg G, OdebergJ, Blombäck M. Validation of a composite score for clinical severity of hemophilia. J Thromb Haemost 2008;6:1113-21.
11. Lippi G, Guidi G. Risk factors for cardiovascular disease. CMAJ 2002;166:710.
12. Ding K, Kullo IJ. Evolutionary genetics of coronary heart disease. Circulation 2009;119:459-67.
13. Schunkert H, König IR, Erdmann J. Molecular signatures of cardiovascular disease risk: potential for test development and clinical application. Mol DiagnTher 2008;12:281-7.
14. Lanktree M, Oh J, Hegele RA. Genetic testing for atherosclerosis risk: inevitability or pipe dream? Can J Cardiol 2008;24:851-4.
15. Lippi G, Salvagno GL, Targher G, Guidi GC. Multiple biomarkers for the prediction of first major cardiovascular events and death: considerable costs and limited benefits. MedGenMed 2007;9:34.
16. Scheuner MT. Genetic evaluation for coronary artery disease. Genet Med 2003;5:269-85.
17. Bussey HI, Wittkowsky AK, Hylek EM, Walker MB. Genetic testing for warfarin dosing? Not yet ready for prime time. Pharmacotherapy 2008;28:141-3.
18. Lippi G, Salvagno GL, Guidi GC. Genetic factors for warfarin dose prediction. Clin Chem 2007;53:1721-2.
19. Lippi G, Salvagno GL, Guidi GC. Genetic analysis to prevent warfarin complications. CMAJ 2007; 177:377.
20. Lippi G, Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci2003;40:1-42.
21. Lippi G, Braga V, Adami S, Guidi G. Modification of serum apolipopro-tein A-I, apolipoprotein B and lipoprotein(a) levels after bisphospho-nates-induced acute phase response. Clin ChimActa 1998;271:79-87.
22. Lippi G, Targher G, Franchini M, Guidi GC. Biochemical correlates ofli-poprotein(a) in a general adult population. Possible implications for cardiovascular risk assessment. J Thromb Thrombolysis 2009;27:44-7.
23. Lippi G, Franchini M, Guidi GC. Lipoprotein(a), athero-thrombosis and longevity. A historical paradox finally elucidated? Haematologica 2007;92:e48.
24. Lippi G, Guidi G. Biochemical risk factors and patient's outcome: the case of lipoprotein(a). Clin ChimActa 1999;280:59-71.
25. Lippi G, Plebani M, Guidi GC. The paradox in translational medicine. Clin Chem 2007;53:1553.
26. Plebani M. The changing scenario in laboratory medicine and the role of laboratory professionals in translational medicine. Clin Chim Ac-ta 2008;393:23-6.
27. Plebani M, Marincola FM. Research translation: a new frontier for clinical laboratories. Clin Chem Lab Med 2006;44:1303-12.
28. Lippi G, Franchini M, Montagnana M, Guidi GC. Genomics and pro-teomics in venous thromboembolism: building a bridge toward a rational personalized medicine framework. Semin Thromb Hemost 2007;33:759-70.
29. Lippi G, Fostini R, Guidi GC. Quality improvement in laboratory medicine: extra-analytical issues. Clin Lab Med 2008;28:285-94.
30. Plebani M. The clinical importance of laboratory reasoning. Clin Chim Acta 1999;280:35-45.
31. Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6:95-108.
32. Li M, Li C, Guan W. Evaluation of coverage variation ofSNP chips for genome-wide association studies. Eur J Hum Genet 2008;16:635-43.
33. Lippi G, Siest G, Plebani M. Pharmacy-based laboratory services: past or future and risk or opportunity? Clin Chem Lab Med 2008;46:435-6.